nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP2C9—Gefitinib—lung cancer	0.0622	0.104	CbGbCtD
Metronidazole—CYP2C9—Teniposide—lung cancer	0.0603	0.1	CbGbCtD
Metronidazole—CYP2C8—Erlotinib—lung cancer	0.0527	0.0878	CbGbCtD
Metronidazole—CYP2C8—Paclitaxel—lung cancer	0.0483	0.0803	CbGbCtD
Metronidazole—CYP3A4—Topotecan—lung cancer	0.0395	0.0658	CbGbCtD
Metronidazole—CYP2C8—Etoposide—lung cancer	0.0381	0.0635	CbGbCtD
Metronidazole—CYP3A4—Gefitinib—lung cancer	0.0362	0.0602	CbGbCtD
Metronidazole—CYP3A4—Teniposide—lung cancer	0.0351	0.0584	CbGbCtD
Metronidazole—CYP2C9—Paclitaxel—lung cancer	0.0337	0.056	CbGbCtD
Metronidazole—CYP3A4—Vinorelbine—lung cancer	0.0279	0.0464	CbGbCtD
Metronidazole—CYP2C9—Cisplatin—lung cancer	0.0271	0.0451	CbGbCtD
Metronidazole—CYP3A4—Crizotinib—lung cancer	0.0222	0.0369	CbGbCtD
Metronidazole—CYP3A4—Erlotinib—lung cancer	0.0214	0.0356	CbGbCtD
Metronidazole—CYP3A4—Paclitaxel—lung cancer	0.0196	0.0326	CbGbCtD
Metronidazole—CYP3A4—Irinotecan—lung cancer	0.0193	0.0321	CbGbCtD
Metronidazole—CYP3A4—Vinblastine—lung cancer	0.0172	0.0286	CbGbCtD
Metronidazole—CYP3A4—Etoposide—lung cancer	0.0155	0.0257	CbGbCtD
Metronidazole—CYP3A4—Docetaxel—lung cancer	0.0141	0.0236	CbGbCtD
Metronidazole—CYP3A4—Doxorubicin—lung cancer	0.0105	0.0176	CbGbCtD
Metronidazole—Convulsion—Docetaxel—lung cancer	0.000116	0.000353	CcSEcCtD
Metronidazole—Paraesthesia—Paclitaxel—lung cancer	0.000116	0.000352	CcSEcCtD
Metronidazole—Hypertension—Docetaxel—lung cancer	0.000116	0.000352	CcSEcCtD
Metronidazole—Bronchitis—Doxorubicin—lung cancer	0.000116	0.000351	CcSEcCtD
Metronidazole—Agranulocytosis—Methotrexate—lung cancer	0.000116	0.000351	CcSEcCtD
Metronidazole—Somnolence—Paclitaxel—lung cancer	0.000115	0.000349	CcSEcCtD
Metronidazole—Decreased appetite—Etoposide—lung cancer	0.000115	0.000348	CcSEcCtD
Metronidazole—Arthralgia—Docetaxel—lung cancer	0.000114	0.000347	CcSEcCtD
Metronidazole—Chest pain—Docetaxel—lung cancer	0.000114	0.000347	CcSEcCtD
Metronidazole—Pancytopenia—Doxorubicin—lung cancer	0.000114	0.000347	CcSEcCtD
Metronidazole—Nausea—Vinorelbine—lung cancer	0.000114	0.000347	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Etoposide—lung cancer	0.000114	0.000346	CcSEcCtD
Metronidazole—Dyspepsia—Paclitaxel—lung cancer	0.000114	0.000345	CcSEcCtD
Metronidazole—Body temperature increased—Cisplatin—lung cancer	0.000114	0.000345	CcSEcCtD
Metronidazole—Asthenia—Irinotecan—lung cancer	0.000114	0.000345	CcSEcCtD
Metronidazole—Fatigue—Etoposide—lung cancer	0.000114	0.000345	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000114	0.000345	CcSEcCtD
Metronidazole—Pain—Etoposide—lung cancer	0.000113	0.000342	CcSEcCtD
Metronidazole—Constipation—Etoposide—lung cancer	0.000113	0.000342	CcSEcCtD
Metronidazole—Dysuria—Doxorubicin—lung cancer	0.000113	0.000341	CcSEcCtD
Metronidazole—Neutropenia—Doxorubicin—lung cancer	0.000113	0.000341	CcSEcCtD
Metronidazole—Decreased appetite—Paclitaxel—lung cancer	0.000112	0.000341	CcSEcCtD
Metronidazole—Dry mouth—Docetaxel—lung cancer	0.000112	0.000339	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000112	0.000339	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000112	0.000339	CcSEcCtD
Metronidazole—Fatigue—Paclitaxel—lung cancer	0.000112	0.000338	CcSEcCtD
Metronidazole—CYP2C8—Metapathway biotransformation—CYP2E1—lung cancer	0.000111	0.0016	CbGpPWpGaD
Metronidazole—Hepatitis—Methotrexate—lung cancer	0.000111	0.000337	CcSEcCtD
Metronidazole—Pollakiuria—Doxorubicin—lung cancer	0.000111	0.000337	CcSEcCtD
Metronidazole—Asthenia—Gemcitabine—lung cancer	0.000111	0.000336	CcSEcCtD
Metronidazole—Pain—Paclitaxel—lung cancer	0.000111	0.000336	CcSEcCtD
Metronidazole—Constipation—Paclitaxel—lung cancer	0.000111	0.000336	CcSEcCtD
Metronidazole—Confusional state—Docetaxel—lung cancer	0.000111	0.000335	CcSEcCtD
Metronidazole—Pharyngitis—Methotrexate—lung cancer	0.00011	0.000335	CcSEcCtD
Metronidazole—Photosensitivity reaction—Doxorubicin—lung cancer	0.00011	0.000333	CcSEcCtD
Metronidazole—Anaphylactic shock—Docetaxel—lung cancer	0.00011	0.000333	CcSEcCtD
Metronidazole—Oedema—Docetaxel—lung cancer	0.00011	0.000333	CcSEcCtD
Metronidazole—CYP3A4—Biological oxidations—GSTA3—lung cancer	0.000109	0.00157	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—GSTT1—lung cancer	0.000109	0.00157	CbGpPWpGaD
Metronidazole—Pruritus—Gemcitabine—lung cancer	0.000109	0.000332	CcSEcCtD
Metronidazole—Infection—Docetaxel—lung cancer	0.000109	0.00033	CcSEcCtD
Metronidazole—Feeling abnormal—Etoposide—lung cancer	0.000109	0.00033	CcSEcCtD
Metronidazole—Diarrhoea—Irinotecan—lung cancer	0.000109	0.000329	CcSEcCtD
Metronidazole—CYP2C9—Biological oxidations—GCLC—lung cancer	0.000108	0.00155	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—CYP2A6—lung cancer	0.000108	0.00155	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	0.000108	0.00155	CbGpPWpGaD
Metronidazole—Gastrointestinal pain—Etoposide—lung cancer	0.000108	0.000327	CcSEcCtD
Metronidazole—Shock—Docetaxel—lung cancer	0.000108	0.000327	CcSEcCtD
Metronidazole—Nervous system disorder—Docetaxel—lung cancer	0.000108	0.000326	CcSEcCtD
Metronidazole—Thrombocytopenia—Docetaxel—lung cancer	0.000107	0.000326	CcSEcCtD
Metronidazole—Infestation—Doxorubicin—lung cancer	0.000107	0.000325	CcSEcCtD
Metronidazole—Infestation NOS—Doxorubicin—lung cancer	0.000107	0.000325	CcSEcCtD
Metronidazole—Drowsiness—Doxorubicin—lung cancer	0.000107	0.000325	CcSEcCtD
Metronidazole—Visual impairment—Methotrexate—lung cancer	0.000107	0.000325	CcSEcCtD
Metronidazole—Feeling abnormal—Paclitaxel—lung cancer	0.000107	0.000323	CcSEcCtD
Metronidazole—Skin disorder—Docetaxel—lung cancer	0.000107	0.000323	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000106	0.000323	CcSEcCtD
Metronidazole—Hypersensitivity—Cisplatin—lung cancer	0.000106	0.000322	CcSEcCtD
Metronidazole—Gastrointestinal pain—Paclitaxel—lung cancer	0.000106	0.000321	CcSEcCtD
Metronidazole—Diarrhoea—Gemcitabine—lung cancer	0.000106	0.000321	CcSEcCtD
Metronidazole—CYP2C9—Arachidonic acid metabolism—PTGS2—lung cancer	0.000106	0.00152	CbGpPWpGaD
Metronidazole—Erythema multiforme—Methotrexate—lung cancer	0.000105	0.000319	CcSEcCtD
Metronidazole—Neuropathy peripheral—Doxorubicin—lung cancer	0.000105	0.000319	CcSEcCtD
Metronidazole—Dizziness—Irinotecan—lung cancer	0.000105	0.000318	CcSEcCtD
Metronidazole—Urticaria—Etoposide—lung cancer	0.000105	0.000318	CcSEcCtD
Metronidazole—Jaundice—Doxorubicin—lung cancer	0.000105	0.000317	CcSEcCtD
Metronidazole—Stomatitis—Doxorubicin—lung cancer	0.000105	0.000317	CcSEcCtD
Metronidazole—Anorexia—Docetaxel—lung cancer	0.000105	0.000317	CcSEcCtD
Metronidazole—Abdominal pain—Etoposide—lung cancer	0.000104	0.000316	CcSEcCtD
Metronidazole—Body temperature increased—Etoposide—lung cancer	0.000104	0.000316	CcSEcCtD
Metronidazole—Conjunctivitis—Doxorubicin—lung cancer	0.000104	0.000316	CcSEcCtD
Metronidazole—Urinary tract infection—Doxorubicin—lung cancer	0.000104	0.000316	CcSEcCtD
Metronidazole—Eye disorder—Methotrexate—lung cancer	0.000104	0.000315	CcSEcCtD
Metronidazole—Tinnitus—Methotrexate—lung cancer	0.000104	0.000315	CcSEcCtD
Metronidazole—Asthenia—Cisplatin—lung cancer	0.000103	0.000313	CcSEcCtD
Metronidazole—Cardiac disorder—Methotrexate—lung cancer	0.000103	0.000313	CcSEcCtD
Metronidazole—Sweating—Doxorubicin—lung cancer	0.000103	0.000312	CcSEcCtD
Metronidazole—Urticaria—Paclitaxel—lung cancer	0.000103	0.000312	CcSEcCtD
Metronidazole—Body temperature increased—Paclitaxel—lung cancer	0.000102	0.00031	CcSEcCtD
Metronidazole—Abdominal pain—Paclitaxel—lung cancer	0.000102	0.00031	CcSEcCtD
Metronidazole—Hepatobiliary disease—Doxorubicin—lung cancer	0.000102	0.000308	CcSEcCtD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000101	0.00145	CbGpPWpGaD
Metronidazole—Angiopathy—Methotrexate—lung cancer	0.000101	0.000306	CcSEcCtD
Metronidazole—Vomiting—Irinotecan—lung cancer	0.000101	0.000306	CcSEcCtD
Metronidazole—Sinusitis—Doxorubicin—lung cancer	0.000101	0.000305	CcSEcCtD
Metronidazole—Immune system disorder—Methotrexate—lung cancer	0.000101	0.000305	CcSEcCtD
Metronidazole—Mediastinal disorder—Methotrexate—lung cancer	0.0001	0.000304	CcSEcCtD
Metronidazole—Agranulocytosis—Doxorubicin—lung cancer	0.0001	0.000304	CcSEcCtD
Metronidazole—CYP3A4—Biological oxidations—GSTA4—lung cancer	0.0001	0.00144	CbGpPWpGaD
Metronidazole—Rash—Irinotecan—lung cancer	0.0001	0.000303	CcSEcCtD
Metronidazole—Dermatitis—Irinotecan—lung cancer	0.0001	0.000303	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Docetaxel—lung cancer	9.99e-05	0.000303	CcSEcCtD
Metronidazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	9.98e-05	0.00143	CbGpPWpGaD
Metronidazole—Headache—Irinotecan—lung cancer	9.94e-05	0.000301	CcSEcCtD
Metronidazole—Insomnia—Docetaxel—lung cancer	9.92e-05	0.000301	CcSEcCtD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	9.89e-05	0.00142	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	9.87e-05	0.00142	CbGpPWpGaD
Metronidazole—Diarrhoea—Cisplatin—lung cancer	9.86e-05	0.000299	CcSEcCtD
Metronidazole—Paraesthesia—Docetaxel—lung cancer	9.85e-05	0.000299	CcSEcCtD
Metronidazole—Vomiting—Gemcitabine—lung cancer	9.83e-05	0.000298	CcSEcCtD
Metronidazole—CYP3A4—Biological oxidations—GSTA2—lung cancer	9.75e-05	0.0014	CbGpPWpGaD
Metronidazole—Somnolence—Docetaxel—lung cancer	9.75e-05	0.000296	CcSEcCtD
Metronidazole—Mental disorder—Methotrexate—lung cancer	9.75e-05	0.000296	CcSEcCtD
Metronidazole—Rash—Gemcitabine—lung cancer	9.75e-05	0.000296	CcSEcCtD
Metronidazole—Dermatitis—Gemcitabine—lung cancer	9.74e-05	0.000295	CcSEcCtD
Metronidazole—Hypersensitivity—Etoposide—lung cancer	9.72e-05	0.000295	CcSEcCtD
Metronidazole—Erythema—Methotrexate—lung cancer	9.69e-05	0.000294	CcSEcCtD
Metronidazole—Headache—Gemcitabine—lung cancer	9.68e-05	0.000294	CcSEcCtD
Metronidazole—Rhinitis—Doxorubicin—lung cancer	9.66e-05	0.000293	CcSEcCtD
Metronidazole—Dyspepsia—Docetaxel—lung cancer	9.66e-05	0.000293	CcSEcCtD
Metronidazole—Hepatitis—Doxorubicin—lung cancer	9.64e-05	0.000292	CcSEcCtD
Metronidazole—Hypoaesthesia—Doxorubicin—lung cancer	9.59e-05	0.000291	CcSEcCtD
Metronidazole—Pharyngitis—Doxorubicin—lung cancer	9.56e-05	0.00029	CcSEcCtD
Metronidazole—Decreased appetite—Docetaxel—lung cancer	9.53e-05	0.000289	CcSEcCtD
Metronidazole—Hypersensitivity—Paclitaxel—lung cancer	9.53e-05	0.000289	CcSEcCtD
Metronidazole—Dysgeusia—Methotrexate—lung cancer	9.49e-05	0.000288	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Docetaxel—lung cancer	9.47e-05	0.000287	CcSEcCtD
Metronidazole—Asthenia—Etoposide—lung cancer	9.47e-05	0.000287	CcSEcCtD
Metronidazole—Connective tissue disorder—Doxorubicin—lung cancer	9.47e-05	0.000287	CcSEcCtD
Metronidazole—Fatigue—Docetaxel—lung cancer	9.46e-05	0.000287	CcSEcCtD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	9.45e-05	0.00136	CbGpPWpGaD
Metronidazole—Nausea—Irinotecan—lung cancer	9.42e-05	0.000286	CcSEcCtD
Metronidazole—CYP3A4—Biological oxidations—GSTA1—lung cancer	9.41e-05	0.00135	CbGpPWpGaD
Metronidazole—Constipation—Docetaxel—lung cancer	9.38e-05	0.000284	CcSEcCtD
Metronidazole—Pain—Docetaxel—lung cancer	9.38e-05	0.000284	CcSEcCtD
Metronidazole—Back pain—Methotrexate—lung cancer	9.37e-05	0.000284	CcSEcCtD
Metronidazole—Pruritus—Etoposide—lung cancer	9.34e-05	0.000283	CcSEcCtD
Metronidazole—CYP2C8—Biological oxidations—GSTP1—lung cancer	9.32e-05	0.00134	CbGpPWpGaD
Metronidazole—Visual impairment—Doxorubicin—lung cancer	9.29e-05	0.000282	CcSEcCtD
Metronidazole—Asthenia—Paclitaxel—lung cancer	9.28e-05	0.000282	CcSEcCtD
Metronidazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—lung cancer	9.27e-05	0.00133	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—CYP2E1—lung cancer	9.19e-05	0.00132	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—GSTP1—lung cancer	9.19e-05	0.00132	CbGpPWpGaD
Metronidazole—Nausea—Gemcitabine—lung cancer	9.18e-05	0.000278	CcSEcCtD
Metronidazole—Vomiting—Cisplatin—lung cancer	9.16e-05	0.000278	CcSEcCtD
Metronidazole—Pruritus—Paclitaxel—lung cancer	9.16e-05	0.000278	CcSEcCtD
Metronidazole—Vision blurred—Methotrexate—lung cancer	9.13e-05	0.000277	CcSEcCtD
Metronidazole—Erythema multiforme—Doxorubicin—lung cancer	9.11e-05	0.000276	CcSEcCtD
Metronidazole—Rash—Cisplatin—lung cancer	9.08e-05	0.000275	CcSEcCtD
Metronidazole—Dermatitis—Cisplatin—lung cancer	9.08e-05	0.000275	CcSEcCtD
Metronidazole—CYP2C9—Metapathway biotransformation—CYP2E1—lung cancer	9.07e-05	0.0013	CbGpPWpGaD
Metronidazole—Feeling abnormal—Docetaxel—lung cancer	9.04e-05	0.000274	CcSEcCtD
Metronidazole—Diarrhoea—Etoposide—lung cancer	9.03e-05	0.000274	CcSEcCtD
Metronidazole—Eye disorder—Doxorubicin—lung cancer	9e-05	0.000273	CcSEcCtD
Metronidazole—Tinnitus—Doxorubicin—lung cancer	8.98e-05	0.000272	CcSEcCtD
Metronidazole—Gastrointestinal pain—Docetaxel—lung cancer	8.97e-05	0.000272	CcSEcCtD
Metronidazole—Flushing—Doxorubicin—lung cancer	8.94e-05	0.000271	CcSEcCtD
Metronidazole—Cardiac disorder—Doxorubicin—lung cancer	8.94e-05	0.000271	CcSEcCtD
Metronidazole—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	8.89e-05	0.00128	CbGpPWpGaD
Metronidazole—Diarrhoea—Paclitaxel—lung cancer	8.85e-05	0.000268	CcSEcCtD
Metronidazole—CYP3A4—Biological oxidations—UGT1A1—lung cancer	8.75e-05	0.00126	CbGpPWpGaD
Metronidazole—Angiopathy—Doxorubicin—lung cancer	8.74e-05	0.000265	CcSEcCtD
Metronidazole—Malaise—Methotrexate—lung cancer	8.74e-05	0.000265	CcSEcCtD
Metronidazole—Dizziness—Etoposide—lung cancer	8.73e-05	0.000265	CcSEcCtD
Metronidazole—Immune system disorder—Doxorubicin—lung cancer	8.7e-05	0.000264	CcSEcCtD
Metronidazole—Vertigo—Methotrexate—lung cancer	8.7e-05	0.000264	CcSEcCtD
Metronidazole—Mediastinal disorder—Doxorubicin—lung cancer	8.68e-05	0.000263	CcSEcCtD
Metronidazole—Abdominal pain—Docetaxel—lung cancer	8.67e-05	0.000263	CcSEcCtD
Metronidazole—Body temperature increased—Docetaxel—lung cancer	8.67e-05	0.000263	CcSEcCtD
Metronidazole—Leukopenia—Methotrexate—lung cancer	8.67e-05	0.000263	CcSEcCtD
Metronidazole—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	8.63e-05	0.00124	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—GSTM1—lung cancer	8.56e-05	0.00123	CbGpPWpGaD
Metronidazole—Dizziness—Paclitaxel—lung cancer	8.56e-05	0.000259	CcSEcCtD
Metronidazole—Nausea—Cisplatin—lung cancer	8.56e-05	0.000259	CcSEcCtD
Metronidazole—CYP2C8—Metapathway biotransformation—GSTM1—lung cancer	8.44e-05	0.00121	CbGpPWpGaD
Metronidazole—Mental disorder—Doxorubicin—lung cancer	8.44e-05	0.000256	CcSEcCtD
Metronidazole—Convulsion—Methotrexate—lung cancer	8.39e-05	0.000254	CcSEcCtD
Metronidazole—Vomiting—Etoposide—lung cancer	8.39e-05	0.000254	CcSEcCtD
Metronidazole—Erythema—Doxorubicin—lung cancer	8.39e-05	0.000254	CcSEcCtD
Metronidazole—Rash—Etoposide—lung cancer	8.32e-05	0.000252	CcSEcCtD
Metronidazole—Dermatitis—Etoposide—lung cancer	8.31e-05	0.000252	CcSEcCtD
Metronidazole—Headache—Etoposide—lung cancer	8.27e-05	0.000251	CcSEcCtD
Metronidazole—Flatulence—Doxorubicin—lung cancer	8.27e-05	0.000251	CcSEcCtD
Metronidazole—Chest pain—Methotrexate—lung cancer	8.25e-05	0.00025	CcSEcCtD
Metronidazole—Arthralgia—Methotrexate—lung cancer	8.25e-05	0.00025	CcSEcCtD
Metronidazole—Vomiting—Paclitaxel—lung cancer	8.23e-05	0.000249	CcSEcCtD
Metronidazole—Dysgeusia—Doxorubicin—lung cancer	8.21e-05	0.000249	CcSEcCtD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	8.2e-05	0.00118	CbGpPWpGaD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	8.19e-05	0.000248	CcSEcCtD
Metronidazole—Rash—Paclitaxel—lung cancer	8.16e-05	0.000247	CcSEcCtD
Metronidazole—Dermatitis—Paclitaxel—lung cancer	8.15e-05	0.000247	CcSEcCtD
Metronidazole—CYP2C8—Biological oxidations—CYP1A1—lung cancer	8.12e-05	0.00117	CbGpPWpGaD
Metronidazole—Back pain—Doxorubicin—lung cancer	8.11e-05	0.000246	CcSEcCtD
Metronidazole—Headache—Paclitaxel—lung cancer	8.11e-05	0.000246	CcSEcCtD
Metronidazole—Hypersensitivity—Docetaxel—lung cancer	8.08e-05	0.000245	CcSEcCtD
Metronidazole—Muscle spasms—Doxorubicin—lung cancer	8.06e-05	0.000245	CcSEcCtD
Metronidazole—CYP2C8—Metapathway biotransformation—CYP1A1—lung cancer	8e-05	0.00115	CbGpPWpGaD
Metronidazole—Confusional state—Methotrexate—lung cancer	7.97e-05	0.000242	CcSEcCtD
Metronidazole—Anaphylactic shock—Methotrexate—lung cancer	7.91e-05	0.00024	CcSEcCtD
Metronidazole—Vision blurred—Doxorubicin—lung cancer	7.9e-05	0.00024	CcSEcCtD
Metronidazole—Asthenia—Docetaxel—lung cancer	7.87e-05	0.000239	CcSEcCtD
Metronidazole—Infection—Methotrexate—lung cancer	7.85e-05	0.000238	CcSEcCtD
Metronidazole—Nausea—Etoposide—lung cancer	7.84e-05	0.000238	CcSEcCtD
Metronidazole—Pruritus—Docetaxel—lung cancer	7.76e-05	0.000235	CcSEcCtD
Metronidazole—Nervous system disorder—Methotrexate—lung cancer	7.75e-05	0.000235	CcSEcCtD
Metronidazole—Thrombocytopenia—Methotrexate—lung cancer	7.74e-05	0.000235	CcSEcCtD
Metronidazole—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	7.72e-05	0.00111	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	7.69e-05	0.00111	CbGpPWpGaD
Metronidazole—Nausea—Paclitaxel—lung cancer	7.69e-05	0.000233	CcSEcCtD
Metronidazole—Skin disorder—Methotrexate—lung cancer	7.68e-05	0.000233	CcSEcCtD
Metronidazole—Hyperhidrosis—Methotrexate—lung cancer	7.64e-05	0.000232	CcSEcCtD
Metronidazole—CYP2C9—Biological oxidations—GSTP1—lung cancer	7.58e-05	0.00109	CbGpPWpGaD
Metronidazole—Malaise—Doxorubicin—lung cancer	7.56e-05	0.000229	CcSEcCtD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	7.54e-05	0.00108	CbGpPWpGaD
Metronidazole—Vertigo—Doxorubicin—lung cancer	7.54e-05	0.000229	CcSEcCtD
Metronidazole—Anorexia—Methotrexate—lung cancer	7.54e-05	0.000228	CcSEcCtD
Metronidazole—Syncope—Doxorubicin—lung cancer	7.52e-05	0.000228	CcSEcCtD
Metronidazole—Leukopenia—Doxorubicin—lung cancer	7.51e-05	0.000228	CcSEcCtD
Metronidazole—Diarrhoea—Docetaxel—lung cancer	7.5e-05	0.000228	CcSEcCtD
Metronidazole—CYP2C9—Metapathway biotransformation—GSTP1—lung cancer	7.48e-05	0.00107	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—HPGDS—lung cancer	7.44e-05	0.00107	CbGpPWpGaD
Metronidazole—Palpitations—Doxorubicin—lung cancer	7.41e-05	0.000225	CcSEcCtD
Metronidazole—Loss of consciousness—Doxorubicin—lung cancer	7.37e-05	0.000224	CcSEcCtD
Metronidazole—Convulsion—Doxorubicin—lung cancer	7.27e-05	0.00022	CcSEcCtD
Metronidazole—Dizziness—Docetaxel—lung cancer	7.25e-05	0.00022	CcSEcCtD
Metronidazole—Hypertension—Doxorubicin—lung cancer	7.24e-05	0.00022	CcSEcCtD
Metronidazole—CYP3A4—Biological oxidations—GSTT1—lung cancer	7.21e-05	0.00104	CbGpPWpGaD
Metronidazole—Musculoskeletal discomfort—Methotrexate—lung cancer	7.2e-05	0.000218	CcSEcCtD
Metronidazole—Insomnia—Methotrexate—lung cancer	7.15e-05	0.000217	CcSEcCtD
Metronidazole—Arthralgia—Doxorubicin—lung cancer	7.14e-05	0.000217	CcSEcCtD
Metronidazole—Chest pain—Doxorubicin—lung cancer	7.14e-05	0.000217	CcSEcCtD
Metronidazole—CYP2C8—Metabolism—COL4A3BP—lung cancer	7.14e-05	0.00103	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—AZIN2—lung cancer	7.14e-05	0.00103	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—CYP2A6—lung cancer	7.13e-05	0.00102	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—GCLC—lung cancer	7.13e-05	0.00102	CbGpPWpGaD
Metronidazole—Paraesthesia—Methotrexate—lung cancer	7.1e-05	0.000215	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	7.09e-05	0.000215	CcSEcCtD
Metronidazole—Somnolence—Methotrexate—lung cancer	7.03e-05	0.000213	CcSEcCtD
Metronidazole—Dry mouth—Doxorubicin—lung cancer	6.98e-05	0.000212	CcSEcCtD
Metronidazole—Vomiting—Docetaxel—lung cancer	6.97e-05	0.000211	CcSEcCtD
Metronidazole—CYP2C9—Biological oxidations—GSTM1—lung cancer	6.97e-05	0.001	CbGpPWpGaD
Metronidazole—Dyspepsia—Methotrexate—lung cancer	6.96e-05	0.000211	CcSEcCtD
Metronidazole—Rash—Docetaxel—lung cancer	6.92e-05	0.00021	CcSEcCtD
Metronidazole—Dermatitis—Docetaxel—lung cancer	6.91e-05	0.00021	CcSEcCtD
Metronidazole—Confusional state—Doxorubicin—lung cancer	6.9e-05	0.000209	CcSEcCtD
Metronidazole—CYP2C9—Metapathway biotransformation—GSTM1—lung cancer	6.87e-05	0.000988	CbGpPWpGaD
Metronidazole—Decreased appetite—Methotrexate—lung cancer	6.87e-05	0.000208	CcSEcCtD
Metronidazole—Headache—Docetaxel—lung cancer	6.87e-05	0.000208	CcSEcCtD
Metronidazole—Anaphylactic shock—Doxorubicin—lung cancer	6.85e-05	0.000208	CcSEcCtD
Metronidazole—Oedema—Doxorubicin—lung cancer	6.85e-05	0.000208	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Methotrexate—lung cancer	6.83e-05	0.000207	CcSEcCtD
Metronidazole—Fatigue—Methotrexate—lung cancer	6.82e-05	0.000207	CcSEcCtD
Metronidazole—Infection—Doxorubicin—lung cancer	6.8e-05	0.000206	CcSEcCtD
Metronidazole—Pain—Methotrexate—lung cancer	6.76e-05	0.000205	CcSEcCtD
Metronidazole—Shock—Doxorubicin—lung cancer	6.73e-05	0.000204	CcSEcCtD
Metronidazole—Nervous system disorder—Doxorubicin—lung cancer	6.71e-05	0.000204	CcSEcCtD
Metronidazole—Thrombocytopenia—Doxorubicin—lung cancer	6.7e-05	0.000203	CcSEcCtD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	6.66e-05	0.000957	CbGpPWpGaD
Metronidazole—Skin disorder—Doxorubicin—lung cancer	6.65e-05	0.000202	CcSEcCtD
Metronidazole—Hyperhidrosis—Doxorubicin—lung cancer	6.62e-05	0.000201	CcSEcCtD
Metronidazole—CYP2C9—Biological oxidations—CYP1A1—lung cancer	6.61e-05	0.000949	CbGpPWpGaD
Metronidazole—Anorexia—Doxorubicin—lung cancer	6.53e-05	0.000198	CcSEcCtD
Metronidazole—Nausea—Docetaxel—lung cancer	6.52e-05	0.000198	CcSEcCtD
Metronidazole—CYP2C9—Metapathway biotransformation—CYP1A1—lung cancer	6.51e-05	0.000936	CbGpPWpGaD
Metronidazole—Feeling abnormal—Methotrexate—lung cancer	6.51e-05	0.000198	CcSEcCtD
Metronidazole—Gastrointestinal pain—Methotrexate—lung cancer	6.46e-05	0.000196	CcSEcCtD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	6.45e-05	0.000927	CbGpPWpGaD
Metronidazole—Urticaria—Methotrexate—lung cancer	6.28e-05	0.00019	CcSEcCtD
Metronidazole—Body temperature increased—Methotrexate—lung cancer	6.25e-05	0.000189	CcSEcCtD
Metronidazole—Abdominal pain—Methotrexate—lung cancer	6.25e-05	0.000189	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Doxorubicin—lung cancer	6.24e-05	0.000189	CcSEcCtD
Metronidazole—Insomnia—Doxorubicin—lung cancer	6.19e-05	0.000188	CcSEcCtD
Metronidazole—Paraesthesia—Doxorubicin—lung cancer	6.15e-05	0.000186	CcSEcCtD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	6.11e-05	0.000879	CbGpPWpGaD
Metronidazole—Somnolence—Doxorubicin—lung cancer	6.09e-05	0.000185	CcSEcCtD
Metronidazole—CYP2C8—Metabolism—ATP5H—lung cancer	6.07e-05	0.000872	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—CYP2E1—lung cancer	6.06e-05	0.000871	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—POMC—lung cancer	6.05e-05	0.00087	CbGpPWpGaD
Metronidazole—Dyspepsia—Doxorubicin—lung cancer	6.03e-05	0.000183	CcSEcCtD
Metronidazole—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	5.98e-05	0.000859	CbGpPWpGaD
Metronidazole—Decreased appetite—Doxorubicin—lung cancer	5.95e-05	0.00018	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Doxorubicin—lung cancer	5.91e-05	0.000179	CcSEcCtD
Metronidazole—Fatigue—Doxorubicin—lung cancer	5.9e-05	0.000179	CcSEcCtD
Metronidazole—Pain—Doxorubicin—lung cancer	5.85e-05	0.000178	CcSEcCtD
Metronidazole—Constipation—Doxorubicin—lung cancer	5.85e-05	0.000178	CcSEcCtD
Metronidazole—Hypersensitivity—Methotrexate—lung cancer	5.82e-05	0.000177	CcSEcCtD
Metronidazole—CYP2C9—Metabolism—AZIN2—lung cancer	5.81e-05	0.000835	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—COL4A3BP—lung cancer	5.81e-05	0.000835	CbGpPWpGaD
Metronidazole—Asthenia—Methotrexate—lung cancer	5.67e-05	0.000172	CcSEcCtD
Metronidazole—Feeling abnormal—Doxorubicin—lung cancer	5.64e-05	0.000171	CcSEcCtD
Metronidazole—Gastrointestinal pain—Doxorubicin—lung cancer	5.6e-05	0.00017	CcSEcCtD
Metronidazole—Pruritus—Methotrexate—lung cancer	5.59e-05	0.00017	CcSEcCtD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	5.58e-05	0.000802	CbGpPWpGaD
Metronidazole—Urticaria—Doxorubicin—lung cancer	5.44e-05	0.000165	CcSEcCtD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	5.42e-05	0.000779	CbGpPWpGaD
Metronidazole—Body temperature increased—Doxorubicin—lung cancer	5.41e-05	0.000164	CcSEcCtD
Metronidazole—Abdominal pain—Doxorubicin—lung cancer	5.41e-05	0.000164	CcSEcCtD
Metronidazole—CYP2C8—Metabolism—PLBD1—lung cancer	5.41e-05	0.000778	CbGpPWpGaD
Metronidazole—Diarrhoea—Methotrexate—lung cancer	5.41e-05	0.000164	CcSEcCtD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	5.32e-05	0.000765	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	5.25e-05	0.000754	CbGpPWpGaD
Metronidazole—Dizziness—Methotrexate—lung cancer	5.23e-05	0.000159	CcSEcCtD
Metronidazole—Hypersensitivity—Doxorubicin—lung cancer	5.04e-05	0.000153	CcSEcCtD
Metronidazole—Vomiting—Methotrexate—lung cancer	5.03e-05	0.000152	CcSEcCtD
Metronidazole—CYP3A4—Biological oxidations—GSTP1—lung cancer	5e-05	0.000719	CbGpPWpGaD
Metronidazole—Rash—Methotrexate—lung cancer	4.98e-05	0.000151	CcSEcCtD
Metronidazole—Dermatitis—Methotrexate—lung cancer	4.98e-05	0.000151	CcSEcCtD
Metronidazole—Headache—Methotrexate—lung cancer	4.95e-05	0.00015	CcSEcCtD
Metronidazole—CYP2C8—Metabolism—HSD17B10—lung cancer	4.95e-05	0.000711	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ATP5H—lung cancer	4.94e-05	0.00071	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	4.93e-05	0.000709	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—POMC—lung cancer	4.93e-05	0.000708	CbGpPWpGaD
Metronidazole—Asthenia—Doxorubicin—lung cancer	4.91e-05	0.000149	CcSEcCtD
Metronidazole—Pruritus—Doxorubicin—lung cancer	4.84e-05	0.000147	CcSEcCtD
Metronidazole—Nausea—Methotrexate—lung cancer	4.7e-05	0.000142	CcSEcCtD
Metronidazole—Diarrhoea—Doxorubicin—lung cancer	4.68e-05	0.000142	CcSEcCtD
Metronidazole—CYP2C8—Metabolism—CKB—lung cancer	4.6e-05	0.000661	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—GSTM1—lung cancer	4.6e-05	0.00066	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	4.54e-05	0.000652	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	4.53e-05	0.000651	CbGpPWpGaD
Metronidazole—Dizziness—Doxorubicin—lung cancer	4.53e-05	0.000137	CcSEcCtD
Metronidazole—CYP2C9—Metabolism—PLBD1—lung cancer	4.4e-05	0.000633	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—CYP1A1—lung cancer	4.36e-05	0.000626	CbGpPWpGaD
Metronidazole—Vomiting—Doxorubicin—lung cancer	4.35e-05	0.000132	CcSEcCtD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	4.33e-05	0.000622	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTM2—lung cancer	4.33e-05	0.000622	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CNDP2—lung cancer	4.33e-05	0.000622	CbGpPWpGaD
Metronidazole—Rash—Doxorubicin—lung cancer	4.32e-05	0.000131	CcSEcCtD
Metronidazole—Dermatitis—Doxorubicin—lung cancer	4.31e-05	0.000131	CcSEcCtD
Metronidazole—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	4.3e-05	0.000617	CbGpPWpGaD
Metronidazole—Headache—Doxorubicin—lung cancer	4.29e-05	0.00013	CcSEcCtD
Metronidazole—CYP2C8—Metabolism—MTMR3—lung cancer	4.21e-05	0.000605	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PGAM1—lung cancer	4.1e-05	0.000589	CbGpPWpGaD
Metronidazole—Nausea—Doxorubicin—lung cancer	4.07e-05	0.000123	CcSEcCtD
Metronidazole—CYP2C9—Metabolism—HSD17B10—lung cancer	4.03e-05	0.000579	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP2A7—lung cancer	3.91e-05	0.000562	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—COL4A3BP—lung cancer	3.83e-05	0.000551	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—AZIN2—lung cancer	3.83e-05	0.000551	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—SDC4—lung cancer	3.83e-05	0.00055	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CKB—lung cancer	3.74e-05	0.000538	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTM2—lung cancer	3.52e-05	0.000506	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CNDP2—lung cancer	3.52e-05	0.000506	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTA3—lung cancer	3.49e-05	0.000501	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—RRM1—lung cancer	3.49e-05	0.000501	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—MTMR3—lung cancer	3.42e-05	0.000492	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PGAM1—lung cancer	3.34e-05	0.00048	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—B4GALT5—lung cancer	3.28e-05	0.000471	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ATP5H—lung cancer	3.26e-05	0.000468	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—POMC—lung cancer	3.25e-05	0.000467	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTA4—lung cancer	3.19e-05	0.000458	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP2A7—lung cancer	3.18e-05	0.000458	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.12e-05	0.000448	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—SDC4—lung cancer	3.12e-05	0.000448	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTA2—lung cancer	3.11e-05	0.000447	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTA1—lung cancer	3e-05	0.000431	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ABCC3—lung cancer	2.96e-05	0.000426	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PLBD1—lung cancer	2.9e-05	0.000417	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—AKR1C1—lung cancer	2.87e-05	0.000413	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—RRM1—lung cancer	2.84e-05	0.000408	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTA3—lung cancer	2.84e-05	0.000408	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—UGT1A1—lung cancer	2.79e-05	0.000401	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GNG11—lung cancer	2.69e-05	0.000386	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.67e-05	0.000384	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—B4GALT5—lung cancer	2.67e-05	0.000383	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—HSD17B10—lung cancer	2.66e-05	0.000382	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTA4—lung cancer	2.6e-05	0.000373	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ALDOA—lung cancer	2.56e-05	0.000368	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.54e-05	0.000365	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTA2—lung cancer	2.53e-05	0.000363	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NCOA3—lung cancer	2.48e-05	0.000357	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CKB—lung cancer	2.47e-05	0.000355	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.44e-05	0.000351	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTA1—lung cancer	2.44e-05	0.000351	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ADCY1—lung cancer	2.42e-05	0.000347	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ABCG2—lung cancer	2.42e-05	0.000347	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ABCC3—lung cancer	2.41e-05	0.000347	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ENO2—lung cancer	2.37e-05	0.000341	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—HPGDS—lung cancer	2.37e-05	0.000341	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PPP2R1B—lung cancer	2.36e-05	0.000338	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—AKR1C1—lung cancer	2.34e-05	0.000336	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.32e-05	0.000334	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CNDP2—lung cancer	2.32e-05	0.000334	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTM2—lung cancer	2.32e-05	0.000334	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTT1—lung cancer	2.3e-05	0.00033	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GCLC—lung cancer	2.27e-05	0.000327	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP2A6—lung cancer	2.27e-05	0.000327	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—UGT1A1—lung cancer	2.27e-05	0.000326	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.26e-05	0.000325	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—MTMR3—lung cancer	2.26e-05	0.000325	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PGAM1—lung cancer	2.2e-05	0.000316	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GNG11—lung cancer	2.19e-05	0.000314	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.18e-05	0.000313	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ENO1—lung cancer	2.15e-05	0.00031	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.15e-05	0.000308	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.12e-05	0.000304	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP2A7—lung cancer	2.1e-05	0.000302	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ALDOA—lung cancer	2.08e-05	0.000299	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SDC4—lung cancer	2.05e-05	0.000295	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NCOA3—lung cancer	2.02e-05	0.000291	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.99e-05	0.000286	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ABCG2—lung cancer	1.97e-05	0.000283	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ADCY1—lung cancer	1.97e-05	0.000283	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP2E1—lung cancer	1.93e-05	0.000278	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ENO2—lung cancer	1.93e-05	0.000277	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—HPGDS—lung cancer	1.93e-05	0.000277	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.92e-05	0.000275	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NQO1—lung cancer	1.91e-05	0.000275	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.89e-05	0.000272	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTA3—lung cancer	1.87e-05	0.000269	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—RRM1—lung cancer	1.87e-05	0.000269	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTT1—lung cancer	1.87e-05	0.000269	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.87e-05	0.000269	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.85e-05	0.000266	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GCLC—lung cancer	1.85e-05	0.000266	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP2A6—lung cancer	1.85e-05	0.000266	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.84e-05	0.000265	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—B4GALT5—lung cancer	1.76e-05	0.000253	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ENO1—lung cancer	1.75e-05	0.000252	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.75e-05	0.000251	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.72e-05	0.000248	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—STK11—lung cancer	1.72e-05	0.000247	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTA4—lung cancer	1.71e-05	0.000246	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTA2—lung cancer	1.67e-05	0.00024	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.62e-05	0.000232	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTA1—lung cancer	1.61e-05	0.000231	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTP1—lung cancer	1.59e-05	0.000229	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ABCC3—lung cancer	1.59e-05	0.000229	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP2E1—lung cancer	1.57e-05	0.000226	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NQO1—lung cancer	1.55e-05	0.000223	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CAT—lung cancer	1.55e-05	0.000223	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.54e-05	0.000222	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—AKR1C1—lung cancer	1.54e-05	0.000221	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.52e-05	0.000219	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.51e-05	0.000217	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ABCB1—lung cancer	1.51e-05	0.000217	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—UGT1A1—lung cancer	1.5e-05	0.000215	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—TYMS—lung cancer	1.48e-05	0.000213	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTM1—lung cancer	1.46e-05	0.00021	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GNG11—lung cancer	1.44e-05	0.000207	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—STK11—lung cancer	1.4e-05	0.000201	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP1A1—lung cancer	1.39e-05	0.000199	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ERCC2—lung cancer	1.38e-05	0.000198	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ALDOA—lung cancer	1.37e-05	0.000197	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NCOA3—lung cancer	1.33e-05	0.000192	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.32e-05	0.000189	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ADCY1—lung cancer	1.3e-05	0.000186	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ABCG2—lung cancer	1.3e-05	0.000186	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTP1—lung cancer	1.3e-05	0.000186	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ENO2—lung cancer	1.27e-05	0.000183	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—HPGDS—lung cancer	1.27e-05	0.000183	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.26e-05	0.000182	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CAT—lung cancer	1.26e-05	0.000181	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.25e-05	0.00018	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTT1—lung cancer	1.23e-05	0.000177	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ABCB1—lung cancer	1.23e-05	0.000176	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GCLC—lung cancer	1.22e-05	0.000175	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP2A6—lung cancer	1.22e-05	0.000175	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—TYMS—lung cancer	1.21e-05	0.000173	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTM1—lung cancer	1.19e-05	0.000171	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—APOA1—lung cancer	1.19e-05	0.000171	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ENO1—lung cancer	1.16e-05	0.000166	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.14e-05	0.000164	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP1A1—lung cancer	1.13e-05	0.000162	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ERCC2—lung cancer	1.12e-05	0.000161	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PIK3CG—lung cancer	1.09e-05	0.000156	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP2E1—lung cancer	1.04e-05	0.000149	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—POMC—lung cancer	1.03e-05	0.000149	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NQO1—lung cancer	1.03e-05	0.000147	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CREBBP—lung cancer	1.01e-05	0.000145	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—APOA1—lung cancer	9.69e-06	0.000139	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PIK3CD—lung cancer	9.56e-06	0.000137	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ALB—lung cancer	9.43e-06	0.000136	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.28e-06	0.000133	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—STK11—lung cancer	9.24e-06	0.000133	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PIK3CG—lung cancer	8.85e-06	0.000127	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTP1—lung cancer	8.55e-06	0.000123	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—POMC—lung cancer	8.42e-06	0.000121	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PIK3CB—lung cancer	8.33e-06	0.00012	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CAT—lung cancer	8.32e-06	0.00012	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PTGS2—lung cancer	8.25e-06	0.000119	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CREBBP—lung cancer	8.2e-06	0.000118	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ABCB1—lung cancer	8.1e-06	0.000116	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—TYMS—lung cancer	7.95e-06	0.000114	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTM1—lung cancer	7.86e-06	0.000113	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PIK3CD—lung cancer	7.78e-06	0.000112	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ALB—lung cancer	7.68e-06	0.00011	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP1A1—lung cancer	7.45e-06	0.000107	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ERCC2—lung cancer	7.39e-06	0.000106	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PTEN—lung cancer	7.2e-06	0.000103	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—EP300—lung cancer	6.87e-06	9.87e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PIK3CB—lung cancer	6.78e-06	9.74e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PTGS2—lung cancer	6.72e-06	9.65e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—APOA1—lung cancer	6.39e-06	9.19e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PTEN—lung cancer	5.86e-06	8.42e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PIK3CG—lung cancer	5.84e-06	8.39e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—EP300—lung cancer	5.59e-06	8.03e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—POMC—lung cancer	5.55e-06	7.98e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CREBBP—lung cancer	5.41e-06	7.78e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PIK3CD—lung cancer	5.13e-06	7.37e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PIK3CA—lung cancer	5.08e-06	7.3e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ALB—lung cancer	5.06e-06	7.28e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PIK3CB—lung cancer	4.47e-06	6.43e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PTGS2—lung cancer	4.43e-06	6.37e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—AKT1—lung cancer	4.15e-06	5.96e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PIK3CA—lung cancer	4.13e-06	5.94e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PTEN—lung cancer	3.86e-06	5.55e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—EP300—lung cancer	3.68e-06	5.3e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—AKT1—lung cancer	3.38e-06	4.85e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PIK3CA—lung cancer	2.73e-06	3.92e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—AKT1—lung cancer	2.23e-06	3.2e-05	CbGpPWpGaD
